Mr. Ibrahem/Heparin
Clinical data
Pronunciation/ˈhɛpərɪn/ HEP-ər-in
AHFS/Drugs.comMonograph
Pregnancy
category
Routes of
administration
IV, SQ
Legal status
Legal status
  • US: ℞-only
  • In general: ℞ (Prescription only)
Pharmacokinetic data
BioavailabilityErratic
MetabolismLiver
Elimination half-life1.5 hours
ExcretionUrine[2]
Identifiers
Chemical and physical data
FormulaC12H19NO20S3
Molar mass12000–15000 g/mol
  • InChI=1S/C26H41NO34S4/c1-4(28)27-7-9(30)8(29)6(2-52-63(43,44)45)53-24(7)56-15-10(31)11(32)25(58-19(15)21(36)37)55-13-5(3-62(40,41)42)14(60-64(46,47)48)26(59-22(13)38)57-16-12(33)17(61-65(49,50)51)23(39)54-18(16)20(34)35/h5-19,22-26,29-33,38-39H,2-3H2,1H3,(H,27,28)(H,34,35)(H,36,37)(H,40,41,42)(H,43,44,45)(H,46,47,48)(H,49,50,51)/t5-,6+,7+,8+,9+,10+,11+,12-,13-,14+,15-,16-,17+,18+,19-,22-,23?,24+,25+,26-/m0/s1 checkY
  • Key:ZFGMDIBRIDKWMY-PASTXAENSA-N checkY
 ☒NcheckY (what is this?)  (verify)

Heparin, also known as unfractionated heparin (UFH), is a medication and naturally occurring glycosaminoglycan.[4][6] As a medication it is used as an anticoagulant (blood thinner).[4] Specifically it is used in the treatment of heart attacks, unstable angina, and to prevent and treat blood clots in either veins or arteries.[4][3] It is given by injection into a vein or under the skin.[4] Other uses include inside test tubes and kidney dialysis machines.[6][7]

Common side effects include bleeding, pain at the injection site, and low blood platelets.[4] Serious side effects include heparin-induced thrombocytopenia.[4] Greater care is needed in those with poor kidney function.[4] Heparin appears to be relatively safe for use during pregnancy and breastfeeding.[8] Heparin is produced by basophils and mast cells in all mammals.[9]

The discovery of heparin was announced in 1916.[10] It is on the World Health Organization's List of Essential Medicines.[11] The wholesale cost in the developing world, when used for prevention, is about US$9.63–37.95 per month.[12] In the United States it costs about $25–50 per month.[13] A fractionated version of heparin, known as low molecular weight heparin, is also available.[14]


References

change
  1. Heparin Sodium injection Archived 2013-09-05 at the Wayback Machine
  2. heparin. In: Lexi-Drugs Online [database on the Internet]. Hudson (OH): Lexi-Comp, Inc.; 2007 [cited 2/10/12]. Available from: http://online.lexi.com Archived 2012-02-15 at the Wayback Machine. subscription required to view.
  3. 3.0 3.1 Cite error: The named reference MSF2020 was used but no text was provided for refs named (see the help page).
  4. 4.0 4.1 4.2 4.3 4.4 4.5 4.6 4.7 "Heparin Sodium". The American Society of Health-System Pharmacists. Archived from the original on 27 January 2016. Retrieved 1 January 2016.
  5. Cite error: The named reference WHO2020DDD was used but no text was provided for refs named (see the help page).
  6. 6.0 6.1 "Heparin (Mucous ) Injection BP – Summary of Product Characteristics (SPC) – (eMC)". www.medicines.org.uk. September 2016. Archived from the original on 20 December 2016. Retrieved 15 December 2016.
  7. McClatchey, Kenneth D. (2002). Clinical Laboratory Medicine. Lippincott Williams & Wilkins. p. 662. ISBN 9780683307511. Archived from the original on 2017-09-10.
  8. "Heparin Pregnancy and Breastfeeding Warnings". drugs.com. Archived from the original on 27 January 2016. Retrieved 15 January 2016.
  9. Guyton, A. C.; Hall, J. E. (2006). Textbook of Medical Physiology. Elsevier Saunders. p. 464. ISBN 978-0-7216-0240-0.
  10. Li, Jie Jack; Corey, E. J. (2013). Drug Discovery: Practices, Processes, and Perspectives. John Wiley & Sons. p. 189. ISBN 9781118354469. Archived from the original on 2017-09-10.
  11. World Health Organization (2019). World Health Organization model list of essential medicines: 21st list 2019. Geneva: World Health Organization. hdl:10665/325771. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.
  12. "Heparin". International Drug Price Indicator Guide. Archived from the original on 22 January 2018. Retrieved 8 December 2016.
  13. Hamilton, Richart (2015). Tarascon Pocket Pharmacopoeia 2015 Deluxe Lab-Coat Edition. Jones & Bartlett Learning. p. X. ISBN 9781284057560.
  14. Rietschel, Robert L.; Fowler, Joseph F.; Fisher, Alexander A. (2008). Fisher's Contact Dermatitis. PMPH-USA. p. 142. ISBN 9781550093780. Archived from the original on 2017-09-10.